Bayer gets EU nod for new veterinary antibiotic, parasiticide
Monheim, Germany -- The European Commission approved two novel veterinary products including a fluoroquinolone antibiotic and dewormer from Bayer Animal Health.
Monheim, Germany
-- The European Commission approved two novel veterinary products including a fluoroquinolone antibiotic and parasiticide from Bayer Animal Health.
While the approval is for certain European countries, Veraflox® (pradofloxacin) is first veterinary fluoroquinolone from the company in more than 20 years, Bayer reports.
VeraFlox is described as the first next-generation fluoroquinolone antibiotic for the treatment of bacterial infections in dogs and cats. It has been approved in 30 European Union (EU) countries and will be available to those markets soon, Bayer says.
The other product, Procox®, is dubbed the first parasiticide of its kind for the combination treatment of roundworm and coccidia gastrointestinal parasitic infections in dogs, including puppies of at least 2 weeks of age and weighing at least 0.4 kg.
This product was approved in 27 EU countries and is scheduled to hit the market this fall.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
